Crypto News

2 hours ago

Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength

Stocks

Abbott (ABT) Q1 2026 earnings beat revenue estimates at $11.16B. EPS at $1.15. Exact Sciences acquisition and medical devices fuel results.

The post Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$CLAW Token Scam$DBKSF$ENA$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token$SPTZ

Latest News